Pathfinder Cell Therapy Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 3
Employees
  • Stock Symbol
  • PFND
Stock Symbol
  • Investments
  • 1

Pathfinder Cell Therapy General Information

Description

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Contact Information

Formerly Known As
Pathfinder
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PINX
Primary Office
  • 12 Bow Street
  • Cambridge, MA 02138
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathfinder Cell Therapy Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
83.9K

Pathfinder Cell Therapy Financials Summary

In Thousands,
USD
TTM 30-Sep-2015 FY 2014 31-Dec-2014 FY 2013 31-Dec-2013 FY 2012 31-Dec-2012
EV 10,568 5,315 11,173 15,588
Revenue 0 0 54 114
EBITDA (772) (1,116) (1,499) (2,040)
Net Income (1,080) (1,394) (1,705) (2,156)
Total Assets 39 106 155 356
Total Debt 5,413 4,983 3,989 2,254
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pathfinder Cell Therapy Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pathfinder Cell Therapy‘s full profile, request access.

Request a free trial

Pathfinder Cell Therapy Patents

Pathfinder Cell Therapy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6579951-B1 Reverse thermal gellation; increasing viscosity as function of temperature Expired - Lifetime 08-Jun-1999 00000000000 00
US-20030187148-A1 Polyesterether copolymer; heat sensitive elements Granted 08-Jun-1999 00000000000 00
US-20050095302-A1 Chain extended or crosslinked polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymers; polyesterether copolymers; reducing adhesions subsequent to surgery or medical procedure; low viscosity at room temperature; high viscosity at high temperature Granted 08-Jun-1999 00000000000 0
US-7569643-B2 Chain extended or crosslinked polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymers; polyesterether copolymers; reducing adhesions subsequent to surgery or medical procedure; low viscosity at room temperature; high viscosity at high temperature Expired - Fee Related 08-Jun-1999 00000000000 0
US-6870012-B2 Polyesterether copolymer; heat sensitive elements Expired - Lifetime 08-Jun-1999 C08G65/3324 00

Pathfinder Cell Therapy Executive Team (1)

Name Title Board Seat Contact Info
John Benson Chief Financial Officer
To view Pathfinder Cell Therapy’s complete executive team members history, request access »

Pathfinder Cell Therapy Board Members (3)

Name Representing Role Since
00000 00000 Pathfinder Cell Therapy Board Member 000 0000
00000 000000 Pathfinder Cell Therapy Board Member 000 0000
0000000 00000000 00.0 Pathfinder Cell Therapy Chairman & Board Member 000 0000
To view Pathfinder Cell Therapy’s complete board members history, request access »

Pathfinder Cell Therapy Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pathfinder Cell Therapy Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pathfinder Cell Therapy‘s full profile, request access.

Request a free trial

Pathfinder Cell Therapy Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 06-Sep-2011 000000000000000000 Therapeutic Devices
To view Pathfinder Cell Therapy’s complete acquisitions history, request access »